Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. GuangZhou YouXing Cosmetic Co., Ltd
WARNING LETTER
•GuangZhou YouXing Cosmetic Co., Ltd•October 8, 2020

GuangZhou YouXing Cosmetic Co., Ltd – FDA Warning Letter, Oct 8, 2020

Record Details

The FDA issued a Warning Letter to GuangZhou YouXing Cosmetics Co. LTD. on September 30, 2021, after laboratory testing revealed their V&W ADVANCE HAND SANITIZER REFRESHING GEL (240ml/8oz) was subpotent. The product, labeled to contain 75% v/v ethyl alcohol, was found to contain only an average of 35% v/v ethanol, leading to its detention and refusal of admission into the U.S. The FDA determined the product is adulterated under section 501(c) of the FD&C Act due to its subpotency and under section 501(a)(2)(B) because the subpotency indicates a failure of the firm's quality assurance system to comply with Current Good Manufacturing Practice (CGMP) requirements. Additionally, the hand sanitizer is an unapproved new drug, marketed in violation of sections 505(a) and 301(d) of the FD&C Act, as it is not generally recognized as safe and effective (GRASE) and does not conform to applicable monographs or temporary COVID-19 policies. It is also misbranded under section 502(a) due to false and misleading labeling regarding its active ingredient concentration, and under section 502(ee) for failing to comply with marketing requirements for nonprescription drugs under section 505G. All drugs from the firm were placed on Import Alert 66-78. The firm must provide a detailed investigation into the subpotency, lists of raw materials and suppliers, a reconciliation of all distributed batches, and complete batch records within 15 working days. The FDA strongly recommends engaging a qualified CGMP consultant if the firm intends to resume manufacturing for the U.S. market.

Company
GuangZhou YouXing Cosmetic Co., Ltd
Inspection date
October 8, 2020
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · 278fd02c-aeda-4b47-89f3-c2cc2ec32f9d

Violation Codes10
21 U.S.C. 351(c)21.U.S.C. 355(a)21 U.S.C. 352(a)21 U.S.C. 352(ee)21 U.S.C. 331(d)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(g)(1)(C)21 U.S.C. 321(p)21 U.S.C. 355h21 U.S.C. 355

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore GuangZhou YouXing Cosmetic Co., Ltd
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.